Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CAMBRIDGE, Mass. e LONDRA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) ha annunciato oggi la partecipazione di Saurabh Saha, M.D., Ph.D e Chief Executive Officer,...
-
CAMBRIDGE, Massachusetts & LONDRES, 02 sept. 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq : CNTA) a annoncé aujourd'hui que Saurabh Saha, M.D., Ph.D., président-directeur...
-
CAMBRIDGE, Massachusetts en LONDEN, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) kondigde vandaag aan dat Saurabh Saha, M.D., Ph.D., Chief Executive Officer, zal...
-
КЕМБРИДЖ, Массачусетс, ЛОНДОН, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) объявила сегодня, что Saurabh Saha, доктор медицины, доктор философии, главный...
-
CAMBRIDGE, Massachusetts y LONDRES, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) ha anunciado hoy que el doctor en medicina Saurabh Saha, director ejecutivo de la...
-
CAMBRIDGE, Mass. und LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) gab heute bekannt, dass Saurabh Saha, M.D., Ph.D., Chief Executive Officer, am Dienstag,...
-
CAMBRIDGE, Mass. & LONDON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will...
-
~ Successful completion of an initial public offering of American Depositary Shares raising gross proceeds of $379.5 million to help advance portfolio of 16 clinical and preclinical programs ~ ~...
-
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate...
-
CAMBRIDGE, Mass. and LONDON, June 04, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Centessa”), a clinical-stage company employing its innovative asset-centric business model to...